Cargando…

A Proposal for Early Dosing Regimens in Heart Transplant Patients Receiving Thymoglobulin and Calcineurin Inhibition

There is currently no consensus regarding the dose or duration of rabbit antithymocyte globulin (rATG) induction in different types of heart transplant patients, or the timing and intensity of initial calcineurin inhibitor (CNI) therapy in rATG-treated individuals. Based on limited data and personal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barten, Markus J., Schulz, Uwe, Beiras-Fernandez, Andres, Berchtold-Herz, Michael, Boeken, Udo, Garbade, Jens, Hirt, Stephan, Richter, Manfred, Ruhpawar, Arjang, Schmitto, Jan Dieter, Schönrath, Felix, Schramm, Rene, Schweiger, Martin, Wilhelm, Markus, Zuckermann, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946520/ https://www.ncbi.nlm.nih.gov/pubmed/27500271 http://dx.doi.org/10.1097/TXD.0000000000000594

Ejemplares similares

A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients
por: Schweiger, Martin, et al.
Publicado: (2018)

Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression
por: Zuckermann, Andreas, et al.
Publicado: (2015)

An avoidable cause of thymoglobulin anaphylaxis
por: Brabant, S., et al.
Publicado: (2017)

Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients
por: Kamar, Nassim, et al.
Publicado: (2008)

New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

Thymoglobulin – new approaches to optimal outcomes
por: Delia Moiceanu, Andreea, et al.
Publicado: (2009)

Current Trends in Implantable Left Ventricular Assist Devices
por: Garbade, Jens, et al.
Publicado: (2011)

Fluoroscopy-Guided Resolution of Ingested Thrombus Leading to Functional Disturbance of a Continuous-Flow Left Ventricular Assist Device
por: Garbade, Jens, et al.
Publicado: (2012)

BK Virus: A Cause for Concern in Thoracic Transplantation?
por: Barten, Markus J., et al.
Publicado: (2018)

Biventricular Levitronix CentriMag Assist Device: A “Bridge to Recovery” Solution in Patients with Acute Fulminant Myocarditis
por: Vollroth, Marcel, et al.
Publicado: (2012)

Severe Intraoperative Anaphylaxis Related to Thymoglobulin during Living Donor Kidney Transplantation
por: Saeed, Muhammad I., et al.
Publicado: (2020)

Grafalon® vs. Thymoglobulin® as an Induction Agent in Renal Transplantation – A Retrospective Study
por: Jha, Pranaw Kumar, et al.
Publicado: (2021)

COVID-19 among heart transplant recipients in Germany: a multicenter survey
por: Rivinius, Rasmus, et al.
Publicado: (2020)

Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT
por: Toor, A, et al.
Publicado: (2008)

Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory Death
por: Asderakis, Argiris, et al.
Publicado: (2022)

Distribution of Cardiac Stem Cells in the Human Heart
por: Arsalan, Mani, et al.
Publicado: (2012)

Mitral Valve Regurgitation: A Severe Complication following Left Ventricular Biopsy 15 Years after Heart Transplantation
por: Vollroth, Marcel, et al.
Publicado: (2013)

Is Thymoglobulin or Rituximab the Cause of This Serum Sickness? A Case Report of Serum Sickness Dilemma and Literature Review
por: Sandhu, Amarpreet, et al.
Publicado: (2012)

Thymoglobulin Induction Dosing Strategies in a Low-Risk Kidney Transplant Population: Three or Four Days?
por: Hardinger, Karen L., et al.
Publicado: (2010)

Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis
por: Barten, Markus J., et al.
Publicado: (2022)

First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001‐2012
por: Bacigalupo, Andrea, et al.
Publicado: (2018)

Enhancing Beta Cell Replacement Therapies: Exploring Calcineurin Inhibitor-Sparing Immunosuppressive Regimens
por: Caldara, Rossana, et al.
Publicado: (2023)

Calcineurin
por: Creamer, Trevor P.
Publicado: (2020)

Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures
por: Bonanno, Giuseppina, et al.
Publicado: (2010)

Flow Cytometric Evaluation of T Cell Activation Markers after Cardiopulmonary Bypass
por: Dieterlen, Maja-Theresa, et al.
Publicado: (2014)

Does Rabbit Antithymocyte Globulin (Thymoglobuline®) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation?
por: Guirado, Lluís
Publicado: (2018)

Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study
por: Qiu, Jiang, et al.
Publicado: (2019)

Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Song, Turun, et al.
Publicado: (2020)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
por: Ide, Kentaro, et al.
Publicado: (2011)

La thymoglobuline en traitement d’induction chez les transplantés rénaux à faible risque immunologique: une expérience marocaine
por: Abouzid, Zineb, et al.
Publicado: (2022)

A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal Allotransplantation
por: Sommer, Wiebke, et al.
Publicado: (2021)

Characterization of calcineurin from Cryptococcus humicola and the application of calcineurin in aluminum tolerance
por: Zhang, Lei, et al.
Publicado: (2017)

Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy
por: Stangou, Maria, et al.
Publicado: (2019)

Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis
por: Lindemann, Aylin, et al.
Publicado: (2023)

Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations
por: Kunacheewa, Chutima, et al.
Publicado: (2020)

Calcineurin in development and disease
por: Chen, Lei, et al.
Publicado: (2021)

Everolimus in Heart Transplantation: An Update
por: Hirt, Stephan W., et al.
Publicado: (2013)

HLA-haploidentical hematopoietic stem cell transplantation with low-dose thymoglobulin GVHD prophylaxis for an adult T cell leukemia/lymphoma patient treated with pretransplant mogamulizumab
por: Hirosawa, Makoto, et al.
Publicado: (2016)

Balanced interactions of calcineurin with AKAP79 regulate Ca(2+)–calcineurin–NFAT signaling
por: Li, Huiming, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vr3telba7qru2g29shmm3rbu5t